Management of Gram-negative and fungal endocarditis

Int J Antimicrob Agents. 2010 Dec:36 Suppl 2:S40-5. doi: 10.1016/j.ijantimicag.2010.11.012. Epub 2010 Dec 3.

Abstract

Infective endocarditis is infrequently caused by Gram-negative bacteria or fungi. Gram-negative organisms are responsible for <4% of cases, whilst fungal endocarditis accounts for <1.5% of culture-positive cases worldwide. Endocarditis due to Gram-negative organisms or fungi is a rare but severe disease. It often has a nosocomial origin, is caused by virulent and often resistant organisms and presents a high rate of complications and high mortality. In this article we present the most recent literature data and address the current management of Gram-negative and fungal infective endocarditis. We also discuss the major challenges of antimicrobial treatment and discuss some issues related to surgical decision-making in difficult-to-manage cases. We finally present our centre's experience with Gram-negative infective endocarditis, with a special focus on the demanding issues that the management of these complex and severely ill patients raise.

Publication types

  • Review

MeSH terms

  • Anti-Infective Agents / therapeutic use
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Cross Infection / mortality
  • Endocarditis / drug therapy*
  • Endocarditis / epidemiology
  • Endocarditis / microbiology*
  • Endocarditis / mortality
  • Gram-Negative Bacterial Infections / drug therapy*
  • Gram-Negative Bacterial Infections / epidemiology
  • Gram-Negative Bacterial Infections / microbiology*
  • Gram-Negative Bacterial Infections / mortality
  • Humans
  • Mycoses / drug therapy*
  • Mycoses / epidemiology
  • Mycoses / microbiology*
  • Mycoses / mortality
  • Prevalence

Substances

  • Anti-Infective Agents